Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links

Drugs

-

Didanosine (marketed as Videx and Videx EC) Information

-

Related Information

Podcast for Healthcare Professionals: Serious Liver Disorder Associated with the Use of Videx/Videx EC
FDA Drug Safety Communication: Serious liver disorder associated with the use of Videx/Videx EC (didanosine)
1/29/2010
Early Communication about an Ongoing Safety Review of Ziagen (Abacavir) and Videx (Didanosine) [ARCHIVED]
7/24/2008

-

-

Labeling and Regulatory History from Drugs@FDA

Didanosine (marketed as Videx and Videx EC) Prescribing and Labeling Information

-

Contact FDA

1-800-332-1088

1-800-FDA-0178 Fax

Report a Serious Problem

MedWatch Online

Regular Mail: Use postage-paid FDA Form 3500

Mail to: MedWatch 5600 Fishers Lane

Rockville, MD 20857

-

-